The market is estimated to be worth USD 75 billion in 2013, and expected to be the second largest in the world by 2017 at USD 160 billion, with average annual growth over the decade five times higher than that of the global pharmaceutical sector.
The industry is composed of very different players, whose average operating margins are still very low (between 3% and 4%) in relation to their Western rivals.
The distribution is almost exclusively via wholesalers (~15% of the market) or retail pharmacies systematically associated with a hospital (obliged by law), usually a public hospital.
The industry is composed of very different players, whose average operating margins are still very low (between 3% and 4%) in relation to their Western rivals.
The distribution is almost exclusively via wholesalers (~15% of the market) or retail pharmacies systematically associated with a hospital (obliged by law), usually a public hospital.
